GEDi Cube, an AI/ML platform that combines differential molecular capabilities with multi-omic analysis to detect cancer at its earliest stage, is delighted to announce the appointment of Dr Lester Russell as Chief Medical Officer. A seasoned expert and leader in clinical medicine and digital health, Lester will be responsible for leading on clinician engagement, clinical validation, and clinical quality assurance as GEDi Cube transitions to the testing and go-to-market phase for its AI/ML platform.
Company Information
Company
Renovaro
Location
Amsterdam, North Holland, Netherlands
About
Renovaro Inc. is a trailblazer in AI-driven early cancer diagnostics and therapeutics. The company aims to accelerate precision and personalized medicine for longevity, powered by mutually reinforcing AI and biotechnology platforms for early diagnosis, better-targeted treatments, and drug discovery. RenovaroCube, as a molecular data science company, has developed an award-winning AI platform that is committed to the early detection of cancer and its recurrence and monitoring subsequent treatments.
Fundz sees it the moment Renovaro changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
AmsterdamBiotechnologyHealth CareArtificial IntelligenceMedicalMachine LearningHealth Diagnostics